Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Apr 25, 2024 - 3:59PM >>   ABB 6410.95 [ 1.07 ]ACC 2579.7 [ 0.85 ]AMBUJA CEM 637.75 [ -0.99 ]ASIAN PAINTS 2860.05 [ -0.25 ]AXIS BANK 1127.35 [ 5.98 ]BAJAJ AUTO 8736.05 [ 0.61 ]BANKOFBARODA 268.7 [ 3.67 ]BHARTI AIRTE 1334.9 [ -0.10 ]BHEL 271.6 [ 2.90 ]BPCL 603.7 [ 1.78 ]BRITANIAINDS 4830 [ 0.04 ]CIPLA 1405.4 [ 0.47 ]COAL INDIA 452.75 [ 2.10 ]COLGATEPALMO 2794.9 [ 1.72 ]DABUR INDIA 506 [ -0.65 ]DLF 895.55 [ 0.20 ]DRREDDYSLAB 6217.15 [ 4.47 ]GAIL 208 [ 0.31 ]GRASIM INDS 2375 [ 1.55 ]HCLTECHNOLOG 1503.65 [ 1.62 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1510.65 [ -0.02 ]HEROMOTOCORP 4500 [ 2.36 ]HIND.UNILEV 2231 [ -1.25 ]HINDALCO 646.5 [ 1.60 ]ICICI BANK 1113.05 [ 1.48 ]IDFC 124.35 [ 0.20 ]INDIANHOTELS 577.5 [ -5.06 ]INDUSINDBANK 1495.95 [ 1.44 ]INFOSYS 1438.4 [ 0.46 ]ITC LTD 437.5 [ 2.02 ]JINDALSTLPOW 942.75 [ 0.68 ]KOTAK BANK 1643 [ -10.85 ]L&T 3650.65 [ 0.43 ]LUPIN 1589.1 [ 0.57 ]MAH&MAH 2095.55 [ 1.76 ]MARUTI SUZUK 12900 [ -0.31 ]MTNL 37.35 [ 0.03 ]NESTLE 2562.7 [ 2.39 ]NIIT 107.6 [ 0.14 ]NMDC 252.3 [ 1.73 ]NTPC 358.3 [ 1.92 ]ONGC 282.05 [ 0.97 ]PNB 135.85 [ 2.10 ]POWER GRID 292.6 [ 0.71 ]RIL 2918.4 [ 0.61 ]SBI 812.6 [ 5.10 ]SESA GOA 380.8 [ -0.64 ]SHIPPINGCORP 232.75 [ 5.10 ]SUNPHRMINDS 1520.55 [ 2.30 ]TATA CHEM 1114.9 [ -1.02 ]TATA GLOBAL 1105.95 [ -0.35 ]TATA MOTORS 1000.8 [ 0.93 ]TATA STEEL 167.6 [ 1.27 ]TATAPOWERCOM 431.5 [ 0.74 ]TCS 3851.85 [ 0.54 ]TECH MAHINDR 1190.1 [ 0.34 ]ULTRATECHCEM 9683.6 [ 0.27 ]UNITED SPIRI 1191.85 [ 0.88 ]WIPRO 461 [ 0.17 ]ZEETELEFILMS 142.75 [ 1.89 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 532321ISIN: INE010B01027INDUSTRY: Pharmaceuticals

BSE   ` 953.50   Open: 937.15   Today's Range 925.20
953.75
+20.10 (+ 2.11 %) Prev Close: 933.40 52 Week Range 482.55
1031.30
Year End :2023-03 

Zydus Lifesciences Limited

(formerly known as Cadila Healthcare Limited)

Report on the Audit of the Standalone FinancialStatements

Opinion

We have audited the accompanying standalone financial statements of Zydus Lifesciences Limited ("the Company”), which comprise the Balance Sheet as at March 31, 2023, and the Statement of Profit and Loss (including Other Comprehensive Income), the Cash Flow Statement and the Statement of Changes in Equity for the year then ended, and a summary of significant accounting policies and other explanatory information in which are incorporated the Returns of the branch located at Philippines, audited by the branch auditor.

In our opinion and to the best of our information and according to the explanations given to us, and based on the consideration of the report of the branch auditor on separate financial statements of the branch referred to in Other Matters section below, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 ("the Act”) in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as amended, ("Ind AS”) and other accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2023, and its profit, total comprehensive income, its cash flows and the changes in equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial statements in accordance with the Standards on Auditing ("SAs”) specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the Auditor's Responsibility for the Audit of the Standalone Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India ("ICAI”) together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the Rules made thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us and the audit evidence obtained by the branch auditor in terms of their report referred to in the Other Matters section below, is sufficient and appropriate to provide a basis for our audit opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of the current year. These matters were addressed in the context of our audit of the standalone financial statements as a whole, and in forming our opinion thereon, we do not provide a separate opinion on these matters. We have determined the matter described below to be the key audit matter to be communicated in our report.

Key Audit Matter

Auditor's Response

Assessment of impairment of non-current investments in equity

The audit procedures performed by us included the following:

shares / common stock of and unsecured loans given to certain

• Evaluated the design and tested the operating effectiveness

subsidiaries namely, Zydus International Private Limited (ZIPL),

of the internal controls relating to review of impairment

Zydus Worldwide DMCC (ZWDMCC) and Sentynl Therapeutics

assessment process, including those over the forecast

Inc (STI) having aggregate carrying values of ? 6,148 million

of future revenues growth rate, terminal values and the

and ? 26,275 million respectively as at March 31, 2023, in the

selection of the appropriate discount rate.

standalone financial statements and also unsecured loans of ?

• Evaluated the reasonableness of the key estimates by

17,215 million given by certain subsidiaries to ZWDMCC and its

subsidiaries where the Company would have indirect exposure

comparing the forecasts to historical revenues, growth rate

by way of investment in such other subsidiaries. [refer

etc.

Notes 2{(19)(A)(b)(v)}, 4, 5 and 13 to the standalone financial

• With the assistance of our internal fair value specialists,

statements]

evaluated the reasonableness of the valuation

As at March 31, 2023, the net worth of these two subsidiary

methodology, discount rate and perpetual growth rate

groups and the subsidiary, have been substantially eroded.

The Company has accordingly tested the carrying value of

• Performed sensitivity analysis around the key estimates to

investments in and loans to these subsidiary groups and the

ascertain the extent of change in those assumptions that

subsidiary for impairment. Based on the said exercise of testing

either individually or collectively would be required for the

for impairment, the Company has recognised impairment

investments and loans tested to be impaired.

allowance of f 2,038 million during the year ended March 31,

• Tested the mathematical and clerical accuracy of the

2023 in respect of investment made in STI, as described in note

model to conclude that the model is accurately calculating

46 of the standalone financial statements.

the value in use, using the appropriate methodology.

The Company's evaluation of impairment of its investments in

and expected credit loss of the loans given involves comparison

of their recoverable amounts to their corresponding carrying

amounts.

The recoverable amounts is determined based on value in use,

which represents the present value of the estimated future

cash flows expected to arise from the use of the asset group

comprising each cash generating unit. There is a risk that the

aforesaid assets will be impaired if these cash flows do not meet

the Company's expectations.

In addition to significance of the amounts involved,

management's assessment process is complex as it involves

significant judgement in determining the assumptions to be

used to estimate the forecasted cash flows, principally relating

to long-term revenue growth rates, perpetual growth rate and

the discount rate used.

Considering the materiality of the amounts involved together

with the inherent subjectivity related to principal assumptions

and probability of defaults by the said entities in fulfilling their

contractual obligations, investments and loans in these two

subsidiary groups and the subsidiary have been considered as

a key audit matter.

Information Other than the Financial Statements and Auditor's Report Thereon

• The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Management Discussion and Analysis, Business Responsibility and Sustainability Report, Board's Report and Corporate Governance Report, but does not include the consolidated financial statements, standalone financial statements and our auditor's report thereon.

• Our opinion on the standalone financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

• In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained during the course of our audit or otherwise appears to be materially misstated.

• If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Responsibilities of Management and Those Charged with Governance for the Standalone Financial Statements

The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with the Ind AS and other accounting principles generally accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Company's Board of Directors are also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibility for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be

expected to influence the economic decisions of users taken on the basis of these standalone financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• I dentify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal financial control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to standalone financial statements in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the management.

• Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the standalone financial statements, including the disclosures, and whether the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

• Obtain sufficient appropriate audit evidence regarding the financial information of the Company and its branch to express an opinion on the standalone financial statements. We are responsible for the direction, supervision and performance of the audit of the financial statements of such entity and its business activities included in the standalone financial statements of which we are the independent auditors. For the other entity and its business activities included in the standalone financial statements, which have been audited by the branch auditor, such branch

auditor remain responsible for the direction, supervision and performance of the audit carried out by them. We remain solely responsible for our audit opinion.

Materiality is the magnitude of misstatements in the standalone financial statements that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the standalone financial statements may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the standalone financial statements.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Other Matters

We did not audit the financial statements of the branch included in the standalone financial statements of the Company whose financial statements reflect total assets of f 10.18 million as at December 31, 2022 and total revenue of f 0.17 million for the year ended on that date, as considered in the standalone financial statements. The financial statements of this branch have been audited by the branch auditor whose report has been furnished to us. The reporting date of the branch at December 31, 2022 is different from the reporting date of the Company. In our opinion and according to the information and explanations given to us by the Board of Directors, these financial statements are not material to the Company, accordingly, no adjustments have been made by the Management of the Company in respect of financial information of the branch for the periods from January 1, 2022 to March 31, 2022 and January 1, 2023 to March 31, 2023. Our opinion in so far as it relates to the amounts and disclosures included in respect of this branch and our report in terms of subsection (3) of Section 143 of the Act, in so far as it relates to the aforesaid branch, is based solely on the report of such branch auditor.

Our opinion on the standalone financial statements and our report on Other Legal and Regulatory Requirements below is not modified in respect of these matters.

Report on Other Legal and Regulatory Requirements

1. As required by Section 143(3) of the Act, based on our audit and on the consideration of the report of the branch auditor on the separate financial statements of the branch, referred to in the Other Matters section above, we report, to the extent applicable that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit.

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books.

c) The reports on the accounts of the branch office of the Company audited under Section 143(8) of the Act by the branch auditor have been sent to us and have been properly dealt with by us in preparing this report.

d) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, the Cash Flow Statement and Statement of Changes in Equity dealt with by this Report are in agreement with the books of account.

e) In our opinion, the aforesaid standalone financial statements comply with the Ind AS specified under Section 133 of the Act.

f) On the basis of the written representations received from the directors as on March 31, 2023 taken on record by the Board of Directors, none of the directors is disqualified as on March 31, 2023 from being appointed as a director in terms of Section 164(2) of the Act.

g) With respect to the adequacy of the internal financial controls with reference to standalone financial statements of the Company and the operating effectiveness of such controls, refer to our separate Report in "Annexure A”. Our report expresses an unmodified opinion on the adequacy and operating effectiveness of the Company's internal financial controls with reference to standalone financial statements.

h) With respect to the other matters to be included in the Auditor's Report in accordance with the requirements of section 197(16) of the Act, as amended, in our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the Company to its directors during the year is in accordance with the provisions of section 197 of the Act.

i) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its standalone financial statements - Refer Note 28 to the standalone financial statements;

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company.

iv. (a) The Management has represented that,

to the best of their knowledge and belief, other than as disclosed in Note 49(a) to the financial statements, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other persons or entities, including foreign entities (“Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company ("Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(b) The Management has represented, that, to the best of their knowledge and belief, other than as disclosed in Note 49(b) to the financial statements, no funds have been received by the Company from any persons or entities, including foreign entities (“Funding Parties”), with the understanding, whether recorded in writing or otherwise, that the Company shall, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party ("Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(c) Based on the audit procedures performed that have been considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (i) and (ii) of Rule 11(e), as provided under (a) and (b) above, contain any material misstatement.

v. The final dividend proposed in the previous year, declared and paid by the Company during the year is in accordance with section 123 of the Act, as applicable.

As stated in Note 29 to the standalone financial statements, the Board of Directors of the Company has proposed final dividend for the year which is subject to the approval of the members at the ensuing Annual General Meeting. The dividend proposed is in accordance with section 123 of the Act, as applicable.

vi. Proviso to Rule 3(1) of the Companies (Accounts) Rules, 2014 for maintaining books of account using accounting software which has a feature of recording audit trail (edit log) facility is applicable to the Company with effect from April 1, 2023, and accordingly, reporting under Rule 11(g) of Companies (Audit and Auditors) Rules, 2014 is not applicable for the financial year ended March 31, 2023.

2. As required by the Companies (Auditor's Report) Order, 2020 (“the Order”) issued by the Central Government in terms of Section 143(11) of the Act, we give in “Annexure B” a statement on the matters specified in paragraphs 3 and 4 of the Order.